RENE,Cartesian Growth Corporation II | Financials

Financials

RENE

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Cartesian Growth Corporation IIRENE

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

154.96M

Revenue (ttm)

n/a

Net Income (ttm)

8.21M

Shares Out

13.00M

EPS (ttm)

0.40

PE Ratio

29.52

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

Open

11.92

Previous Close

11.83

Day's Range

11.92 - 11.94

52-Week Range

11.17 - 11.94

Beta

-0.01

Analysts

n/a

Price Target

n/a

Earnings Date

n/a

Description >

Cartesian Growth Corporation II does not have significant operations.

It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities.

Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.

Latest News >

The Medicine Box: India can become leader of innovative drugs, funding huge challenge, says Dr Reddy’s GV Prasad

Jan 6, 2022

The Medicine Box Podcast: In this edition, CNBC-TV18’s Ekta Batra gets in conversation with Dr Reddy’s Laboratories’ co-chairman and MD, GV Prasad, to discuss India’s potential to become a leader in making innovative drugs, the growth so far, and the associated challenges.

India vs South Africa 2nd Test, Day 3: SA reaches 118 for 2 in chase of 240

Jan 5, 2022

India vs South Africa 2nd Test: India removed opener Aiden Markaram (34) and Keegan Petersen (28) but the home batters ensured there were no more setbacks after that. Earlier, resuming at 85 for two, India put on board 266 runs.

US CDC recommends Pfizer booster for 12- to 15-year-olds amid Omicron surge

Jan 6, 2022

Boosters already are recommended for everyone 16 and older, and federal regulators have decided they're also warranted for 12- to 15-year-olds once enough time has passed since their last dose.

Opening Bell: Sensex, Nifty open sharply lower amid weak global cues; Airtel, Sun Pharma rise

Jan 6, 2022

The Indian equity benchmark indices opened sharply lower on Thursday with Nifty50 down 1 percent. There were not many gainers on the index this morning, the top ones are Hindalco, Sun Pharma, Cipla, DRL, and Airtel.